Agnico (AEM) Upgraded to Buy: Here's What You Should Know — Positive

AEM   Zacks Investment Research — October 13, 2025

Agnico (AEM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Agnico (AEM) Upgraded to Buy: Here's What You Should Know

Equinix (EQIX) Upgraded to Strong Buy: Here's What You Should Know — Positive

EQIX   Zacks Investment Research — October 13, 2025

Equinix (EQIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news Equinix (EQIX) Upgraded to Strong Buy: Here's What You Should Know

Supernus Pharmaceuticals (SUPN) Is Up 2.81% in One Week: What You Should Know — Positive

SUPN   Zacks Investment Research — October 13, 2025

Does Supernus Pharmaceuticals (SUPN) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Supernus Pharmaceuticals (SUPN) Is Up 2.81% in One Week: What You Should Know

Prenetics Global Limited (PRE) Is Up 13.52% in One Week: What You Should Know — Positive

PRE   Zacks Investment Research — October 13, 2025

Does Prenetics Global Limited (PRE) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Prenetics Global Limited (PRE) Is Up 13.52% in One Week: What You Should Know

Here's Why Ballard Power Systems (BLDP) is a Great Momentum Stock to Buy — Positive

BLDP   Zacks Investment Research — October 13, 2025

Does Ballard Power Systems (BLDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Here's Why Ballard Power Systems (BLDP) is a Great Momentum Stock to Buy

Remitly Global (RELY) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive

RELY   Zacks Investment Research — October 13, 2025

Remitly Global (RELY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news Remitly Global (RELY) Upgraded to Strong Buy: What Does It Mean for the Stock?

Olaplex (OLPX) Upgraded to Buy: Here's Why — Positive

OLPX   Zacks Investment Research — October 13, 2025

Olaplex (OLPX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Olaplex (OLPX) Upgraded to Buy: Here's Why

Virtus (VRTS) Upgraded to Buy: Here's Why — Positive

VRTS   Zacks Investment Research — October 13, 2025

Virtus (VRTS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Virtus (VRTS) Upgraded to Buy: Here's Why

Kinross Gold (KGC) Moves to Buy: Rationale Behind the Upgrade — Positive

KGC   Zacks Investment Research — October 13, 2025

Kinross Gold (KGC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Kinross Gold (KGC) Moves to Buy: Rationale Behind the Upgrade

JPMorgan to invest $1.5 trillion in U.S. national security — Positive

JPM   The Street — October 13, 2025

It's a 10-year long plan. Transcript: JP Morgan is betting big on America's future.

image for news JPMorgan to invest $1.5 trillion in U.S. national security

Cessna Citation Ascend Makes World Debut at NBAA-BACE in Las Vegas — Neutral

TXT   Business Wire — October 13, 2025

LAS VEGAS--(BUSINESS WIRE)--The Cessna Citation Ascend landed today at Henderson Executive Airport in Las Vegas, marking its world debut at the 2025 National Business Aviation Association Business Aviation Convention & Exhibition (NBAA-BACE). The aircraft, which flew to the show using sustainable aviation fuel, will be on display Tuesday, October 14 and Wednesday, 15 alongside other industry-leading Cessna Citation business jets. The Cessna Citation Ascend is designed and manufactured by Te.

image for news Cessna Citation Ascend Makes World Debut at NBAA-BACE in Las Vegas

Gold, silver soar to record highs amid short squeeze in silver — Positive

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  SIL  SILJ  SIVR  SLV  SLVP  UGL   Kitco — October 13, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold, silver soar to record highs amid short squeeze in silver

Top Stock Movers Now: Broadcom, Warner Bros. Discovery, Bloom Energy, and More — Neutral

AVGO  BE  WBD   Investopedia — October 13, 2025

Major U.S.stock indexes rose sharply Monday morning after President Donald Trump softened his tone on China. The Dow Jones Industrial Average, S&P 500 and Nasdaq Composite were each up at least 1.3% in recent trading, recovering from a selloff on Friday.

image for news Top Stock Movers Now: Broadcom, Warner Bros. Discovery, Bloom Energy, and More

Dutch Bros Tightens Cost Controls: Are Margin Gains Sustainable? — Positive

BROS   Zacks Investment Research — October 13, 2025

BROS' Q2 margins edge higher on cost cuts and labor gains, but rising coffee prices may weigh on near-term growth.

image for news Dutch Bros Tightens Cost Controls: Are Margin Gains Sustainable?

CAMBRIDGE, Mass. , Oct. 13, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced an upcoming poster presentation further characterizing the preclinical intracranial activity of its novel HER2-selective inhibitor, NVL-330, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held October 22-26, 2025 in Boston.

image for news Nuvalent to Present New Preclinical Data for HER2-Selective Inhibitor, NVL-330, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Will Strong Pricing & Ad Growth Lift NFLX's Margins and Drive Upside? — Positive

NFLX   Zacks Investment Research — October 13, 2025

Netflix lifts its 2025 margin outlook to 30% as strong pricing power and booming ad growth drive profitability and engagement.

image for news Will Strong Pricing & Ad Growth Lift NFLX's Margins and Drive Upside?

German American Bancorp (GABC) Could Be a Great Choice — Positive

GABC   Zacks Investment Research — October 13, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does German American Bancorp (GABC) have what it takes?

image for news German American Bancorp (GABC) Could Be a Great Choice

Are You Looking for a High-Growth Dividend Stock? — Positive

AEE   Zacks Investment Research — October 13, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ameren (AEE) have what it takes?

image for news Are You Looking for a High-Growth Dividend Stock?

Why Fulton Financial (FULT) is a Great Dividend Stock Right Now — Positive

FULT   Zacks Investment Research — October 13, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Fulton Financial (FULT) have what it takes?

image for news Why Fulton Financial (FULT) is a Great Dividend Stock Right Now

Why Artesian Resources (ARTNA) is a Great Dividend Stock Right Now — Positive

ARTNA   Zacks Investment Research — October 13, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Artesian Resources (ARTNA) have what it takes?

image for news Why Artesian Resources (ARTNA) is a Great Dividend Stock Right Now